Surgical resection of advanced non-small cell lung cancer after a response to EGFR-TKI: presentation of two cases and a literature review

BACKGROUND: The usefulness of residual tumor resection after epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment remains unclear. We describe two patients who underwent residual tumor resection after responding to EGFR-TKIs for advanced non-small cell lung cancer (NSCLC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Yoko, Kodama, Ken, Maniwa, Tomohiro, Takeda, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701362/
https://www.ncbi.nlm.nih.gov/pubmed/29169381
http://dx.doi.org/10.1186/s13019-017-0668-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701362/
https://www.ncbi.nlm.nih.gov/pubmed/29169381
http://dx.doi.org/10.1186/s13019-017-0668-3

Ejemplares similares